In conclusion, several Nifty 50 stocks, including Cipla, Sun Pharma and Infosys, experienced declines in Wednesday's trading ...

Join us on the Cipla Stock Liveblog, your hub for real-time updates and comprehensive analysis on a prominent stock. Stay in ...

Nifty Pharma dropped 0.66% at intraday as it underperformed benchmark Nifty 50 which dropped 0.46% at intraday.

On the Nifty, Hero MotoCorp, Cipla, Bajaj Finserv, Maruti Suzuki, and JSW Steel emerged as early gainers. On the flip side, ...

Positive index contributors on the Nifty 50 include Trent, Hero Motocorp, Bajaj Finserv, Cipla and Titan Company as of 9:25 am on Thursday, August 7, 2025.

Mumbai: Cipla has announced that the United States Food and Drug Administration (USFDA) has classified the current Good ...

Cipla has announced that the United States Food and Drug Administration (USFDA) has classified its recent inspection of the company's manufacturing facility in Bommasandra, Bengaluru as Voluntary ...

Biocon and Aurobindo Pharma are identified as facing significant EPS impacts within the generics and biosimilars domain.

GAAP revenue dropped to zero in Q2 2025, with no new product sales or clinical trial sponsorships. Net loss per share (GAAP) was $(0.42) in Q2 2025, reflecting significant spending cuts and a ...

As global demand for next-generation therapies on diabetes and weight loss surges, Indian pharmaceutical companies are ...

Mumbai: Domestic benchmark indices fell marginally on Thursday, weighed down by weakness in automobile, metal, and oil stocks ...

Cipla's stock experienced a significant drop of 2.34% in early trading, making it one of the top losers on the Nifty 50 index.